A case of biopsy‐proven inflammatory dilated cardiomyopathy following heterologous mRNA‐1273 third‐dose immunization

A case of biopsy‐proven inflammatory dilated cardiomyopathy following heterologous mRNA‐1273 third‐dose immunization

Saved in:

Bibliographic Details
Main Authors:	Katsuya Hashimoto, Hiroyuki Yamamoto, Yoshihiko Ikeda, Jun Isogai, Toru Hashimoto
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	ESC Heart Failure
Subjects:	corticosteroid treatment endomyocardial biopsy heterologous immunization inflammatory dilated cardiomyopathy mRNA‐1273 SARS‐CoV‐2 vaccine vaccine‐associated myocarditis
Online Access:	https://doi.org/10.1002/ehf2.14924
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adhered macrophages as an additional marker of cardiomyocyte injury in biopsies of patients with dilated cardiomyopathy
by: Warmusz Oliwia, et al.
Published: (2025-02-01)

Dilated cardiomyopathy and myocarditis: a clinical case
by: O.V. Onyshchenko, et al.
Published: (2023-12-01)

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
by: Amparo L. Figueroa, et al.
Published: (2025-12-01)

Myocarditis following mRNA COVID‐19 vaccination: call for endomyocardial biopsy
by: Daniel Kiblboeck, et al.
Published: (2022-06-01)

Breakhthrough Infection Pasca Pemberian Booster mRNA Heterolog pada Tenaga Kesehatan di RSUD Arifin Achmad
by: Dina Br Nababan, et al.
Published: (2023-04-01)

Evaluating the Effectiveness of mRNA-1273.815 Against COVID-19 Hospitalization Among Adults Aged ≥ 18 Years in the United States
by: Amanda Wilson, et al.
Published: (2024-12-01)

Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vaccine
by: Dandan Peng, et al.
Published: (2023-04-01)

‘Hot phase’ non‐dilated left ventricular cardiomyopathy with atypical onset and recurrence: a case report
by: Nicola Gonano, et al.
Published: (2024-12-01)

Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera
by: Thomas E. Hickey, et al.
Published: (2025-01-01)

Genotype-phenotype insights of pediatric dilated cardiomyopathy
by: Ying Dai, et al.
Published: (2025-01-01)

Correctable Cause of Dilated Cardiomyopathy in an Infant with Heart Failure: ALCAPA Syndrome
by: Osman Güvenç, et al.
Published: (2017-01-01)

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) studyResearch in context
by: Nigel Garrett, et al.
Published: (2025-02-01)

Outcome and prognostic value of N‐terminal pro‐brain natriuretic peptide and high‐sensitivity C‐reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy
by: Jiayu Feng, et al.
Published: (2022-06-01)

Myocarditis Related-COVID-19 mRNA Vaccination: A Narrative Review
by: Idman Gushaendri, et al.
Published: (2023-06-01)

Clinical Features and Outcomes of Pediatric MYH7‐Related Dilated Cardiomyopathy
by: Fernando de Frutos, et al.
Published: (2024-11-01)

Layer-Specific Strain Analysis in Patients with Dilated Cardiomyopathy
by: Despina-Manuela Toader, et al.
Published: (2024-12-01)

The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trial
by: Chunhua Zhou, et al.
Published: (2024-12-01)

Difficulties in diagnosing acute myocarditis by the example of a patient with decompensated chronic heart failure
by: T.M. Shibaeva, et al.
Published: (2024-11-01)

Reviewing the current diagnostic and treatment approaches for myocarditis – analysis of literature
by: Damian Zys, et al.
Published: (2025-01-01)

Comparing Antibody Responses to Homologous vs. Heterologous COVID-19 Vaccination: A Cross-Sectional Analysis in an Urban Bangladeshi Population
by: Kazi Istiaque Sanin, et al.
Published: (2025-01-01)

Dilated cardiomyopathy signature metabolic marker screening: Machine learning and multi-omics analysis
by: Xiao-Lei Li, et al.
Published: (2025-02-01)

Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization
by: William R. Lykins, et al.
Published: (2024-12-01)

Clinical profile of dilated cardiomyopathy in children enrolled in chronic cardiac care: a decade review in a sub-Saharan African tertiary center
by: Henock Gashaw, et al.
Published: (2024-11-01)

Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy
by: Brian P. Halliday, et al.
Published: (2022-06-01)

Thyroid Storm in the Heart: Graves’ Disease Masquerading as Dilated Cardiomyopathy in an Elderly Male
by: Susheel K. Malani, et al.
Published: (2024-12-01)

The value of D-dimer in the prognosis of dilated cardiomyopathy: a retrospective cohort study
by: Yuan Huang, et al.
Published: (2024-11-01)

Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant
by: Gabiria Pastore, et al.
Published: (2024-12-01)

Fungal dilated cardiomyopathy in a child with acute lymphoblastic leukemia, what is the optimal agent and duration in therapy?: A case report
by: Aylin Canbolat Ayhan, et al.
Published: (2014-08-01)

Comparing HeartModelAI and cardiac magnetic resonance imaging for left ventricular volume and function evaluation in patients with dilated cardiomyopathy
by: Mahboobeh Sheikh, et al.
Published: (2024-11-01)

A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children
by: Frances Priddy, et al.
Published: (2024-12-01)

Genetic Polymorphism in Peripartum Cardiomyopathy
by: Ivana Purnama Dewi, et al.
Published: (2021-12-01)

Genomic characteristics, disease outcome and heterologous vaccine effectiveness among cases with SARS CoV-2 infection
by: Rowan Abuyadek, et al.
Published: (2024-11-01)

BMP6, a potential biomarker of inflammatory fibrosis and promising protective factor for dilated cardiomyopathy
by: Feng Jiang, et al.
Published: (2025-01-01)

Gambaran KIPI Vaksin Booster mRNA Heterolog Pada Tenaga Kesehatan RSUD Arifin Achmad Provinsi Riau
by: Carlo Manuel Perangin-angin, et al.
Published: (2023-04-01)

Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
by: Viravarn Luvira, et al.
Published: (2024-12-01)

Association between coronary microvascular dysfunction and exercise capacity in dilated cardiomyopathy
by: Abhishek Dattani, et al.
Published: (2024-01-01)

Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies
by: Tácia Tavares Aquinas Liguori, et al.
Published: (2025-01-01)

A descriptive review on the real-world impact of Moderna, Inc. COVID-19 vaccines
by: Mary Bausch-Jurken, et al.
Published: (2024-12-01)

Prognostic signature and therapeutic drug identification for dilated cardiomyopathy based on necroptosis via bioinformatics and experimental validation
by: Han Yang, et al.
Published: (2025-01-01)

Association between comorbid COPD or chronic bronchitis and the prognosis of patients with Dilated cardiomyopathy
by: Guiting Zhou, et al.
Published: (2024-12-01)